Department of Rehabilitation Medicine, University of Washington, Seattle, USA.
Department of Anesthesiology, University of Washington, Seattle, USA.
Int J Clin Exp Hypn. 2022 Apr-Jun;70(2):156-173. doi: 10.1080/00207144.2022.2052296. Epub 2022 Mar 29.
This randomized, controlled trial tested the impact that hypnosis delivered through immersive virtual reality technology on background pain, anxiety, opioid use, and hospital length of stay in a sample of patients hospitalized for trauma. Participants were randomly assigned to receive either virtual-reality-induced hypnosis, virtual reality for distraction, or usual care during the course of their hospitalization. Mean number of treatment sessions was 3. A total of 153 patients participated in the study. Results indicated no significant differences between the experimental and control conditions on any outcome measures. This study used an early version of virtual reality technology to induce hypnosis and highlighted several important lessons about the challenges of implementation of this technology and how to improve its use in clinical settings.
这项随机对照试验测试了通过沉浸式虚拟现实技术进行的催眠对创伤住院患者背景疼痛、焦虑、阿片类药物使用和住院时间的影响。参与者随机分配接受虚拟现实诱导催眠、虚拟现实分散注意力或住院期间的常规护理。治疗次数的平均值为 3 次。共有 153 名患者参与了这项研究。结果表明，实验组和对照组在任何结果测量指标上均无显著差异。本研究使用了虚拟现实技术的早期版本来诱导催眠，并强调了实施这项技术的挑战和如何改善其在临床环境中的应用的几个重要教训。
